K

Octagon Capital Advisors logo

Octagon Capital Advisors

Crunchbase
Pitchbook
Crunchbase

Deals on record

1

Common Fundraising Type

Series C

Numab Therapeutics logo
Numab Therapeutics

Biotech • Immunotherapies

RTW Investments logo
Novo Holdings logo
Octagon Capital Advisors logo
HBM Healthcare Investment logo

Numab Therapeutics is a biotech company that develops multi-specific antibody-based immunotherapies for inflammation and cancer.

Series C
$55M
01/10/2025
Article